By Trudy Lieberman Mar 17, 2014 at 03:14 PM
When we first took a look at media coverage of Sovaldi, the new wonder drug to treat hepatitis C,... More
By Trudy Lieberman Dec 11, 2013 at 10:50 AM
To hear NPR's piece last week about the FDA's then-imminent approval of a new drug to treat hepatitis C--sofosbuvir, approved... More
Pricey hepatitis C drug Sovaldi “shattered” sales expectations. Reporters need to keep asking the costs and benefits questions.
By Trudy Lieberman Apr 24, 2014 at 02:50 PM
Remember the $1,000-per-pill hepatitis C treatment, Sovaldi, that wowed the press upon FDA approval in December? In the months since,... More
Serial creators don’t know what will happen to Adnan Syed - New developments in his legal case suggest that the outcome is wide open
The press is responsible for ignoring Bill Cosby rape allegations - Where were journalists 10 years ago when claims originally surfaced against him?
Journalism has a plagiarism problem. But it’s not the one you’d expect - Fareed Zakaria’s case highlights news organizations’ ethical grey areas
4 topics John Oliver explained more clearly than television news - The political satirist brings explainer comedy to HBO viewers
Will radio save science journalism? - WNYC will soon have a new health unit
Email blasts from CJR writers and editors
“[T]here was little that justified CNN’s egocentric coverage”
“[I]n spite of all the good reasons not to use the phrase, it is still very easy to find in the US press, even in headlines”
“Right now, my immediate plan is to go to work as a lay therapist at The Intercept to bring the healing there so John Cook and Matt Taibbi can return. I have great interpersonal skills.”
“Like the US drone program itself, this deceitful media practice continues unabated”
Greg Marx discusses democracy and news with Tom Rosenstiel of the American Press Institute
Who Owns What
A report from the Columbia University Graduate School of Journalism
Questions and exercises for journalism students.